I Con 0.03 mg/0.15 mg Tablet
By I Con
Rx
21 Tablet in a Strip

Composition
Ethinyl Estradiol(0.03mg) + Desogestrel(0.15mg)

Manufacturer - Eskag Pharma Pvt Ltd
ESKAG PHARMA PVT. LTD., AG-112, SECTOR-II, SUITE NO.804 & 805, BAISHAKHI, SALT LAKE CITY, KOLKATA-700091

Expires on or after
July, 2025

liver
When using I Con 0.03 mg/0.15 mg Tablet, caution is advised for patients with liver disease. It may be necessary to adjust the dose of I Con 0.03 mg/0.15 mg Tablet in such cases. It is important to consult your doctor before taking this medication. Patients with severe liver disease or active liver disease are not recommended to use I Con 0.03 mg/0.15 mg Tablet.

kidney
Limited information is available on using I Con 0.03 mg/0.15 mg Tablet in patients with kidney disease. Consult your doctor for advice before using.

alcohol
When taking I Con 0.03 mg/0.15 mg Tablet, it is important to be cautious when drinking alcohol. Consult your doctor for guidance on alcohol consumption while on this medication.

driving
It's generally safe to drive while taking I Con 0.03 mg/0.15 mg Tablet as it does not typically impact driving abilities.

pregnancy
During pregnancy, it is not safe to use I Con 0.03 mg/0.15 mg Tablet. Studies have found harmful effects on developing babies. Consult your doctor for guidance.

breastfeeding
I Con 0.03 mg/0.15 mg Tablet should not be used while breastfeeding due to potential toxicity to the baby. It is recommended to consider nonhormonal or progestin-only contraceptives, particularly in the first 4 weeks postpartum.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | GYNAECOLOGICAL |
Action Class | - |
₹195.01
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 18-Nov-2024